Q3 2024 EPS Estimates for AngioDynamics, Inc. Reduced by Zacks Research (NASDAQ:ANGO)
AngioDynamics, Inc. (NASDAQ:ANGO – Free Report) – Zacks Research lowered their Q3 2024 earnings per share (EPS) estimates for AngioDynamics in a research report issued on Wednesday, March 13th. Zacks Research analyst D. Dey now expects that the medical instruments supplier will earn ($0.15) per share for the quarter, down from their previous forecast of […]
More Stories
Fidelity Fundamental Small-Mid Cap ETF (BATS:FSMO) Stock Price Crosses Above 200 Day Moving Average – Here’s Why
Fidelity Fundamental Small-Mid Cap ETF (BATS:FSMO – Get Free Report) shares crossed above its 200-day moving average during trading on...
iShares iBonds Dec 2026 Term Muni Bond ETF (BATS:IBMO) Share Price Pass Above Two Hundred Day Moving Average – Should You Sell?
iShares iBonds Dec 2026 Term Muni Bond ETF (BATS:IBMO – Get Free Report) crossed above its 200-day moving average during...
Cheetah Canyon Resources (CVE:CHTA) Share Price Passes Below 200 Day Moving Average – Time to Sell?
Shares of Cheetah Canyon Resources (CVE:CHTA – Get Free Report) crossed below its 200-day moving average during trading on Thursday...
ProShares K-1 Free Crude Oil ETF (BATS:OILK) Share Price Cross Below 200-Day Moving Average – Here’s What Happened
ProShares K-1 Free Crude Oil ETF (BATS:OILK – Get Free Report) shares passed below its 200-day moving average during trading...
Euclid Capital Growth ETF (BATS:EUCG) Stock Passes Above Two Hundred Day Moving Average – Should You Sell?
Shares of Euclid Capital Growth ETF (BATS:EUCG – Get Free Report) passed above its 200-day moving average during trading on...
Merck & Co., Inc. (NYSE:MRK) Position Boosted by Leelyn Smith LLC
Leelyn Smith LLC raised its holdings in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 2.6% during...